Related Experiment Video
Updated: May 10, 2026

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
Published on: June 4, 2021
Treatment of chronic deep vein thrombosis using ultrasound accelerated catheter-directed thrombolysis
M Dumantepe1, I A Tarhan, A Ozler
1Department of Cardiovascular Surgery, Memorial Atasehir Hospital, Istanbul, Turkey. mdumantepe@gmail.com
Insights
Ultrasound-accelerated catheter-directed thrombolysis (UACDT) shows promise for treating delayed deep venous thrombosis (DVT) of the lower extremities. This method achieved high success rates with minimal complications in a small patient group.
Area of Science:
- Vascular Medicine
- Interventional Radiology
- Thrombosis Research
Background:
- Deep venous thrombosis (DVT) can lead to long-term complications.
- Delayed treatment of DVT presents unique challenges.
- Current treatment options for chronic DVT may have limitations.
Purpose of the Study:
- To assess the feasibility, efficacy, and safety of ultrasound-accelerated catheter-directed thrombolysis (UACDT).
- To evaluate UACDT in patients with delayed lower extremity deep venous thrombosis.
- To determine the outcomes of UACDT in this patient population.
Main Methods:
- Prospective investigation of twelve patients with unilateral iliofemoral or femoropopliteal DVT (mean symptom duration 92 days).
- UACDT performed using recombinant human tissue plasminogen activator with the EKOS EkoSonic system.
- Post-procedure venography, angioplasty/stent placement if needed, and duplex ultrasound follow-up.
Main Results:
- Successful thrombolysis in 11/12 limbs (92%) after a mean infusion time of 26 hours.
- 10/11 veins remained patent at a mean 9-month follow-up.
- Minor bleeding occurred in 2/12 patients; no major hemorrhage or pulmonary embolism.
Conclusions:
- UACDT appears to be a safe and effective option for delayed lower limb DVT treatment.
- This preliminary study supports UACDT as a viable therapeutic approach.
- Further research is warranted to confirm these findings in larger cohorts.
Objective:
To evaluate the feasibility, efficacy and safety of ultrasound-accelerated catheter-directed thrombolysis (UACDT) in the delayed treatment of lower extremity deep venous thrombosis (DVT).
Design:
Twelve patients with unilateral iliofemoral or femoropopliteal DVT (mean symptom duration 92 ± 44 days) were prospectively investigated.
Method:
UACDT was performed using recombinant human tissue plasminogen activator delivered using the EKOS EkoSonic system. Stents were deployed if indicated by post-procedure venography. Follow-up comprised weekly duplex ultrasound for 1 month and monthly thereafter.
Results:
Successful thrombolysis occurred in 11/12 limbs (92%; complete 6/12, partial 5/12) after a mean infusion time of 26 ± 7 hours. 2/12 patients required angioplasty and stent insertion. At a mean follow-up of 9 (6-15) months, 10/11 (91%) veins were patent whereas 1/11 re-occluded at 2 months (patient with protein-C deficiency). 2/11 limbs developed symptoms/signs of post-thrombotic syndrome and 3/11 had developed deep vein reflux (duplex ultrasound). 2/12 patients experienced peri-catheter bleeding but no major hemorrhage or symptomatic pulmonary embolism occurred.
Conclusions:
This preliminary evidence suggests that UACDT may be a safe and effective option for the delayed treatment of lower limb DVT.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis I: Introduction

